Global Information
회사소개 | 문의 | 비교리스트

미국의 조영제 및 방사성 의약품 시장 분석(2019년)

Contrast Agents and Radiopharmaceuticals | Market Analysis | US | 2019

리서치사 Decision Resources Group - Medtech
발행일 2018년 07월 상품 코드 140085
페이지 정보 영문 72 Pages
가격
자세한 내용은 문의바랍니다.

미국의 조영제 및 방사성 의약품 시장 분석(2019년) Contrast Agents and Radiopharmaceuticals | Market Analysis | US | 2019
발행일 : 2018년 07월 페이지 정보 : 영문 72 Pages

미국의 조영제 및 방사성 의약품 시장은 CEUS(조영 증강 초음파 영상) 및 PET 검사 진단에서 조영제 사용이 확대됨에 따라 성장이 촉진될 전망입니다. 그러나 이 시장은 모달리티에 따라 가돌리늄 및 방사선 피폭이라는 건강에 대한 영향이 발생하는 불안정 요소로 인해 성장은 약간 제한될 것으로 예측됩니다. 또한 밸류 기반 케어(환자의 선호도·가치관에 기반한 의료)로의 이동이 가장 정밀하고 선명한 영상을 제공하는 진단 방법의 활용을 지원하고 있는 한편, 이용을 방해하기도 합니다.

미국의 조영제(Contrast Agents) 및 방사성 의약품(Radiopharmaceuticals) 시장 전체와 부문별 시장 개요 및 분석, 경쟁 분석 등을 정리하여 전해드립니다.

제1장 조영제 및 방사성 의약품 시장

  • 시장 하이라이트
  • 시장 정의
  • 시장 예측 데이터
  • 전반적 시장 동향
  • 경쟁 하이라이트
  • 시장 점유율
  • 시장 발전
  • 경쟁요인과 전략

제2장 방사성 의약품 시장

  • 시장 하이라이트
  • 시장 정의
  • 시장 예측 데이터
    • SPECT
    • PET
  • 전반적 시장 동향
  • 경쟁 하이라이트
  • 시장 점유율
  • 경쟁요인과 전략

제3장 CT 및 X선 조영제 시장

  • 시장 하이라이트
  • 시장 정의
  • 시장 예측 데이터
    • CT
    • 심혈관용 X선
    • 일반 X선
  • 전반적 시장 동향
  • 경쟁 하이라이트
  • 시장 점유율
  • 경쟁요인과 전략

제4장 MRI 조영제 시장

  • 시장 하이라이트
  • 시장 정의
  • 시장 예측 데이터
  • 전반적 시장 동향
  • 경쟁 하이라이트
  • 시장 점유율
  • 경쟁요인과 전략

제5장 초음파 조영제 시장

  • 시장 하이라이트
  • 시장 정의
  • 시장 예측 데이터
  • 전반적 시장 동향
  • 경쟁 하이라이트
  • 시장 점유율
  • 경쟁요인과 전략

조사 방법

부록

LSH 18.07.25

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

Growth in the US market for contrast agents and radiopharmaceuticals will be driven by the expanded use of imaging agents in CEUS and PET procedures. However, the market will be somewhat limited by the continued concern over gadolinium and radiation exposure in certain modalities, while the shift to value-based care will hinder the use of some procedures while supporting the use of those that provide the most accuracy and clarity of visualization.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for contrast agents and radiopharmaceuticals in the US across a 10-year period.

The FDA recently expanded approval for the use of CEUS in radiology procedures.

  • What types of procedures does this approval extend to? Which additional procedures could be approved in the future?
  • Which contrast agents received FDA approval?
  • How will competitors that do not have FDA approval react?

Looming concerns over the effects of gadolinium retention will negatively affect the use of contrast-enhanced MRI.

  • How are ACOs, health networks, and physicians responding to the recent findings on gadolinium retention?
  • What are the key differences between linear and macrocyclic GBCAs, and how will market demand for these products shift going forward?
  • Will other imaging modalities cannibalize contrast-enhanced MRI procedures?

While less concerning than in the past, radiation dose concerns still exert a limiting effect on procedure volumes for some imaging modalities.

  • How are US radiologists responding, and what methods are they using to ensure image quality?
  • Which procedures are being cannibalized by other modalities that do not require radiation for image acquisition?

The SPECT radiopharmaceuticals industry is taking precautionary measures to insulate itself from the shortening supply of Mo-99 and Tc-99.

  • What novel technology is showing promise that could help with global supply of Tc-99?
  • How will the transition from HEU to LEU reactors affect ASPs in the US market?

Table of Contents

Table of Contents

Tables and Figures

Executive Summary

Version History

1. Contrast Agent and Radiopharmaceutical Market

  • 1.1. Market Highlights
  • 1.2. Market Definitions
  • 1.3. Market Forecast Data
  • 1.4. General Market Trends
  • 1.5. Competitive Highlights
  • 1.6. Market Shares
  • 1.7. Competitive Factors and Strategies
  • 1.8. Market Developments

2. Radiopharmaceutical Market

  • 2.1. Market Highlights
  • 2.2. Market Definitions
  • 2.3. Market Forecast Data
  • 2.4. General Market Trends
  • 2.5. Competitive Highlights
  • 2.6. Market Shares
  • 2.7. Competitive Factors and Strategies

3. CT and X-Ray Contrast Agent Market

  • 3.1. Market Highlights
  • 3.2. Market Definitions
  • 3.3. Market Forecast Data
  • 3.4. General Market Trends
  • 3.5. Competitive Highlights
  • 3.6. Market Shares
  • 3.7. Competitive Factors and Strategies

4. MRI Contrast Agent Market

  • 4.1. Market Highlights
  • 4.2. Market Definitions
  • 4.3. Market Forecast Data
  • 4.4. General Market Trends
  • 4.5. Competitive Highlights
  • 4.6. Market Shares
  • 4.7. Competitive Factors and Strategies

5. Ultrasound Contrast Agent Market

  • 5.1. Market Highlights
  • 5.2. Market Definitions
  • 5.3. Market Forecast Data
  • 5.4. General Market Trends
  • 5.5. Competitive Highlights
  • 5.6. Market Shares
  • 5.7. Competitive Factors and Strategies

Methodology

  • Core Country Coverage Methodology
  • Supplemental Country Coverage Methodology

Appendix: Acronyms and Initialisms

Appendix: Bibliography

Tables and Figures

  • Table 1: Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, US
  • Figure 1: Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2017--2027
  • Table 2: Contrast Agent and Radiopharmaceutical Market Landscape, US (USD), 2018 and 2027
  • Table 3: Competitive Factors and Strategies, by Product Type, US
  • Table 4: Contrast Agent and Radiopharmaceutical Market Share Rankings, by Product Type, US, 2018
  • Table 5: Companies Mentioned
  • Table 6: Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
  • Table 7: Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
  • Table 8: Contrast Agent and Radiopharmaceutical Procedures and Products Covered, US
  • Table 9: Version History
  • Table 10: Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, US
  • Figure 2: Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2017--2027
  • Table 11: Contrast Agent and Radiopharmaceutical Procedures, by Product Type, US, 2017--2027
  • Table 12: Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2017--2027
  • Figure 3: Contrast Agent and Radiopharmaceutical Revenue Market Shares, US, 2018
  • Table 13: Contrast Agent and Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2018
  • Table 14: Competitive Factors and Strategies, by Product Type, US
  • Table 15: Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
  • Table 16: Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
  • Figure 4: Radiopharmaceutical Market, by Product Type, US (USD), 2017--2027
  • Table 17: Radiopharmaceutical Market, by Product Type, US (USD), 2017--2027
  • Table 18: Radiopharmaceutical Market Growth, by Product Type, US, 2018--2027
  • Table 19: Nuclear Medicine System Installed Base, by Product Type, US, 2017--2027
  • Figure 5: Radiopharmaceutical Revenue Market Shares, US, 2018
  • Table 20: Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2018
  • Table 21: Competitive Factors and Strategies, US
  • Figure 6: CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2017-- 2027
  • Table 22: CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2017-- 2027
  • Table 23: CT and X-Ray Contrast Agent Market Growth, by Product Type, US, 2018-- 2027
  • Table 24: CT and X-Ray System Installed Base, by Product Type, US, 2017--2027
  • Table 25: CT Contrast Agent Market, by Procedure Type, US (USD), 2017--2027
  • Table 26: CT Contrast Agent Market Growth, by Procedure Type, US, 2018--2027
  • Figure 7: CT and X-Ray Contrast Agent Revenue Market Shares, US, 2018
  • Table 27: CT and X-Ray Contrast Agent Revenue Market Shares, US, 2018
  • Table 28: Competitive Factors and Strategies, US
  • Figure 8: MRI Contrast Agent Market, by Procedure Type, US (USD), 2017--2027
  • Table 29: MRI Contrast Agent Market, by Procedure Type, US (USD), 2017--2027
  • Table 30: MRI Contrast Agent Market Growth, by Procedure Type, US, 2018--2027
  • Table 31: MRI System Installed Base, US, 2017--2027
  • Figure 9: MRI Contrast Agent Revenue Market Shares, US, 2018
  • Table 32: MRI Contrast Agent Revenue Market Shares, US, 2018
  • Table 33: Competitive Factors and Strategies, US
  • Figure 10: Ultrasound Contrast Agent Market, US (USD), 2017--2027
  • Table 34: Ultrasound Contrast Agent Market, US (USD), 2017--2027
  • Figure 11: Ultrasound Contrast Agent Revenue Market Shares, US, 2018
  • Table 35: Ultrasound Contrast Agent Revenue Market Shares, US, 2018
  • Table 36: Competitive Factors and Strategies, US
  • Table 37: Acronyms and Initialisms
Back to Top
전화 문의
F A Q